Get the Stockscreener App
1.42
0.00%
0.00
Nephros Inc stock is traded at $1.42, with a volume of 10,358.
It is up +0.00% in the last 24 hours and down -10.13% over the past month.
Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets. In medical markets, it sells water filtration products and waterborne pathogen detection products. In commercial markets, the company manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease.
See More
Previous Close:
$1.42
Open:
$1.49
24h Volume:
10,358
Relative Volume:
0.83
Market Cap:
$14.97M
Revenue:
$14.24M
Net Income/Loss:
$-1.58M
P/E Ratio:
-2.9583
EPS:
-0.48
Net Cash Flow:
$827.00K
1W Performance:
+0.03%
1M Performance:
-10.13%
6M Performance:
-35.45%
1Y Performance:
-12.88%
1-Day Range:
$1.39
$1.49
1-Week Range:
$1.39
$1.50
52-Week Range:
$1.3643
$4.0434
Nephros Inc Stock (NEPH) Company Profile
Name
Nephros Inc
Sector
Industry
Phone
201.343.5202
Address
380 LACKAWANNA PLACE, SOUTH ORANGE, NJ
Nephros Inc Stock (NEPH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-26-21 | Initiated | B. Riley Securities | Buy |
Nephros Inc Stock (NEPH) Latest News
Nephros Schedules Third Quarter 2024 Financial Results Conference Call - The Manila Times
Nephros launches HydraGuard 20″ UltraFilter - Yahoo Finance
Nephros Expands Market Reach with New HydraGuard 20″ UltraFilter - Vancity Buzz
Nephros Launches New HydraGuard 20” UltraFilter - The Manila Times
Nephros stock plunges to 52-week low of $1.43 amid market challenges - Investing.com Australia
Nephros stock plunges to 52-week low of $1.43 amid market challenges By Investing.com - Investing.com South Africa
Nephros helps hospitals and care facilities affected by Hurricanes Helene and Milton - Filtration + Separation
Nephros Provides Critical Water Filtration Solutions in Wake of Hurricanes Helene and Milton - Vancity Buzz
Nephros Delivers Critical Disaster Response to Support Hospitals and Care Facilities Impacted by Hurricanes Helene and Milton - The Manila Times
Nephros Delivers Critical Disaster Response to Support Hospitals and Care Facilities Impacted by Hurricanes - EIN News
Nephros stock plunges to 52-week low of $1.45 amid market challenges By Investing.com - Investing.com South Africa
Nephros Inc (NEPH) Q2 2024 Earnings Call Highlights: Navigating Revenue Challenges with ... - Yahoo Finance
Nephros stock plunges to 52-week low of $1.45 amid market challenges - Investing.com
It's A Story Of Risk Vs Reward With Nephros, Inc. (NASDAQ:NEPH) - Simply Wall St
Medical Water Filter Market Size, Share, Growth and Industry Trends - Third Eye News
Nephros (NASDAQ:NEPH) Stock Price Down 0.7% - Defense World
Peritoneal Dialysis Market Trend and Global Demand 2024 to 2031 - Cineglit
Nephros Shares 2024 Corporate Outlook and Plans - TipRanks
Nephros (NASDAQ:NEPH) Shares Up 0.5% - Defense World
Nephros holds Speculative Buy rating, stock target despite 2Q miss - Investing.com
Nephros holds Speculative Buy rating, stock target despite 2Q miss By Investing.com - Investing.com UK
NEPH (Nephros) 3-Year Revenue Growth Rate : 13.30% (As of Jun. 2024) - GuruFocus.com
Earnings call: Nephros reports mixed Q2 2024 results, focuses on digital tools - Investing.com India
Nephros, Inc. (NASDAQ:NEPH) Q2 2024 Earnings Call Transcript - Insider Monkey
Nephros Second Quarter 2024 Earnings: Misses Expectations - Simply Wall St
US$4.75That's What Analysts Think Nephros, Inc. (NASDAQ:NEPH) Is Worth After These Results - Yahoo Finance
Nephros, Inc. (NEPH) Q2 2024 Earnings Call Transcript - Seeking Alpha
Nephros Announces Financial Results for Quarter Ended June 30, 2024 - wallstreet:online
NEPH Stock Earnings: Nephros Misses EPS, Misses Revenue for Q2 2024 - InvestorPlace
Nephros (NEPH) to Release Quarterly Earnings on Thursday - Defense World
We're Not Worried About Nephros' (NASDAQ:NEPH) Cash Burn - Yahoo Finance
Nephros Schedules Second Quarter 2024 Financial Results Conference Call - StockTitan
Nephros (NASDAQ:NEPH) Trading 0.5% Higher - Defense World
Financial Review: Orchestra BioMed (NASDAQ:OBIO) vs. Nephros (NASDAQ:NEPH) - American Banking and Market News
Nephros Inc. (NEPH) Reports Q2 Loss, Tops Revenue Estimates - Yahoo Canada Shine On
Nephros (NASDAQ:NEPH) Trading Up 0.7% - Defense World
Nephros Hires Wes Lobo as Chief Marketing Officer - Quantisnow
Earnings Outlook For Nephros - Quantisnow
Read This Before Selling Nephros, Inc. (NASDAQ:NEPH) Shares - Yahoo New Zealand News
Pleasing Signs As A Number Of Insiders Buy Nephros Stock - Yahoo Finance
GEE Group And 2 Other Stocks Under $3 Insiders Are Buying - MSN
The Price Is Right For Nephros, Inc. (NASDAQ:NEPH) - Yahoo Sport Australia
GEE Group And 2 Other Stocks Under $3 Insiders Are Buying By Benzinga - Investing.com UK
Nephros director Amron Arthur H buys $11,176 in company stock By Investing.com - Investing.com UK
Chembio (CEMI) Jumps: Stock Rises 7.1% - Yahoo Movies UK
Nephros (NASDAQ:NEPH) Stock Rating Reaffirmed by Benchmark - Defense World
Insider Buying: President and CEO Banks Robert R. Jr. Acquires 50,000 Shares of Nephros Inc (NEPH) - Yahoo Finance UK
Analyzing Nephros (NASDAQ:NEPH) and Nevro (NYSE:NVRO) - Defense World
Nephros Inc Stock (NEPH) Financials Data
Revenue
Net Income
Cash Flow
EPS
Nephros Inc Stock (NEPH) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Amron Arthur H | Director |
May 28 '24 |
Buy |
2.22 |
2,000 |
4,441 |
100,463 |
| Banks Robert R. Jr. | President and CEO |
May 16 '24 |
Buy |
2.24 |
50,000 |
112,050 |
70,000 |
| Amron Arthur H | Director |
Mar 12 '24 |
Buy |
2.45 |
7,000 |
17,130 |
7,000 |
| Banks Robert R. Jr. | President and CEO |
Dec 07 '23 |
Buy |
2.20 |
18,000 |
39,647 |
20,000 |
1.06%
2.17%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):